Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative.
复制标题
DOI:
10.1001/jamanetworkopen.2021.16901
复制
发表时间:
2021-07-01
影响因子:
13.8
通讯作者:
National COVID Cohort Collaborative (N3C) Consortium
中科院分区:
文献类型:
--
作者:
Bennett TD;Moffitt RA;Hajagos JG;Amor B;Anand A;Bissell MM;Bradwell KR;Bremer C;Byrd JB;Denham A;DeWitt PE;Gabriel D;Garibaldi BT;Girvin AT;Guinney J;Hill EL;Hong SS;Jimenez H;Kavuluru R;Kostka K;Lehmann HP;Levitt E;Mallipattu SK;Manna A;McMurry JA;Morris M;Muschelli J;Neumann AJ;Palchuk MB;Pfaff ER;Qian Z;Qureshi N;Russell S;Spratt H;Walden A;Williams AE;Wooldridge JT;Yoo YJ;Zhang XT;Zhu RL;Austin CP;Saltz JH;Gersing KR;Haendel MA;Chute CG;National COVID Cohort Collaborative (N3C) Consortium
In a US data resource large enough to adjust for multiple confounders, what risk factors are associated with COVID-19 severity and severity trajectory over time, and can machine learning models predict clinical severity? In this cohort study of 174 568 adults with SARS-CoV-2, 32 472 (18.6%) were hospitalized and 6565 (20.2%) were severely ill, and first-day machine learning models accurately predicted clinical severity. Mortality was 11.6% overall and decreased from 16.4% in March to April 2020 to 8.6% in September to October 2020. These findings suggest that machine learning models can be used to predict COVID-19 clinical severity with the use of an available large-scale US COVID-19 data resource. The National COVID Cohort Collaborative (N3C) is a centralized, harmonized, high-granularity electronic health record repository that is the largest, most representative COVID-19 cohort to date. This multicenter data set can support robust evidence-based development of predictive and diagnostic tools and inform clinical care and policy. To evaluate COVID-19 severity and risk factors over time and assess the use of machine learning to predict clinical severity. In a retrospective cohort study of 1 926 526 US adults with SARS-CoV-2 infection (polymerase chain reaction >99% or antigen <1%) and adult patients without SARS-CoV-2 infection who served as controls from 34 medical centers nationwide between January 1, 2020, and December 7, 2020, patients were stratified using a World Health Organization COVID-19 severity scale and demographic characteristics. Differences between groups over time were evaluated using multivariable logistic regression. Random forest and XGBoost models were used to predict severe clinical course (death, discharge to hospice, invasive ventilatory support, or extracorporeal membrane oxygenation). Patient demographic characteristics and COVID-19 severity using the World Health Organization COVID-19 severity scale and differences between groups over time using multivariable logistic regression. The cohort included 174 568 adults who tested positive for SARS-CoV-2 (mean [SD] age, 44.4 [18.6] years; 53.2% female) and 1 133 848 adult controls who tested negative for SARS-CoV-2 (mean [SD] age, 49.5 [19.2] years; 57.1% female). Of the 174 568 adults with SARS-CoV-2, 32 472 (18.6%) were hospitalized, and 6565 (20.2%) of those had a severe clinical course (invasive ventilatory support, extracorporeal membrane oxygenation, death, or discharge to hospice). Of the hospitalized patients, mortality was 11.6% overall and decreased from 16.4% in March to April 2020 to 8.6% in September to October 2020 (P = .002 for monthly trend). Using 64 inputs available on the first hospital day, this study predicted a severe clinical course using random forest and XGBoost models (area under the receiver operating curve = 0.87 for both) that were stable over time. The factor most strongly associated with clinical severity was pH; this result was consistent across machine learning methods. In a separate multivariable logistic regression model built for inference, age (odds ratio [OR], 1.03 per year; 95% CI, 1.03-1.04), male sex (OR, 1.60; 95% CI, 1.51-1.69), liver disease (OR, 1.20; 95% CI, 1.08-1.34), dementia (OR, 1.26; 95% CI, 1.13-1.41), African American (OR, 1.12; 95% CI, 1.05-1.20) and Asian (OR, 1.33; 95% CI, 1.12-1.57) race, and obesity (OR, 1.36; 95% CI, 1.27-1.46) were independently associated with higher clinical severity. This cohort study found that COVID-19 mortality decreased over time during 2020 and that patient demographic characteristics and comorbidities were associated with higher clinical severity. The machine learning models accurately predicted ultimate clinical severity using commonly collected clinical data from the first 24 hours of a hospital admission. This cohort study evaluates COVID-19 severity and factors associated with severity over time and assesses the use of machine learning to predict clinical severity.
登录
查看更多内容
DOI:
10.1056/nejmoa2022926
发表时间:
2020-11-19
期刊:
The New England journal of medicine
影响因子:
--
作者:
RECOVERY Collaborative Group;Horby P;Mafham M;Linsell L;Bell JL;Staplin N;Emberson JR;Wiselka M;Ustianowski A;Elmahi E;Prudon B;Whitehouse T;Felton T;Williams J;Faccenda J;Underwood J;Baillie JK;Chappell LC;Faust SN;Jaki T;Jeffery K;Lim WS;Montgomery A;Rowan K;Tarning J;Watson JA;White NJ;Juszczak E;Haynes R;Landray MJ
通讯作者:
Landray MJ
影响因子:
39.2
作者:
Ray, Joel G.;Schull, Michael J.;Park, Alison L.
通讯作者:
Park, Alison L.
影响因子:
15.2
作者:
Brat, Gabriel A.;Weber, Griffin M.;Kohane, Isaac S.
通讯作者:
Kohane, Isaac S.
影响因子:
8.8
作者:
Dennis JM;McGovern AP;Vollmer SJ;Mateen BA
通讯作者:
Mateen BA
DOI:
10.1038/s41584-020-00562-2
发表时间:
2021-03
期刊:
Nature reviews. Rheumatology
影响因子:
--
作者:
Hyrich KL;Machado PM
通讯作者:
Machado PM